BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wareham LK, Liddelow SA, Temple S, Benowitz LI, Di Polo A, Wellington C, Goldberg JL, He Z, Duan X, Bu G, Davis AA, Shekhar K, Torre A, Chan DC, Canto-Soler MV, Flanagan JG, Subramanian P, Rossi S, Brunner T, Bovenkamp DE, Calkins DJ. Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol Neurodegener 2022;17:23. [PMID: 35313950 DOI: 10.1186/s13024-022-00524-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Pezone A, Olivieri F, Napoli MV, Procopio A, Avvedimento EV, Gabrielli A. Inflammation and DNA damage: cause, effect or both. Nat Rev Rheumatol 2023. [PMID: 36750681 DOI: 10.1038/s41584-022-00905-1] [Reference Citation Analysis]
2 Lai Y, Lin T, Chen Y, Lu D. Erythropoietin in Glaucoma: From Mechanism to Therapy. IJMS 2023;24:2985. [DOI: 10.3390/ijms24032985] [Reference Citation Analysis]
3 Huang KC, Gomes C, Shiga Y, Belforte N, VanderWall KB, Lavekar SS, Fligor CM, Harkin J, Di Polo A, Meyer JS. Autophagy disruption reduces mTORC1 activation leading to retinal ganglion cell neurodegeneration associated with glaucoma. bioRxiv 2023:2023. [PMID: 36711831 DOI: 10.1101/2023.01.04.522687] [Reference Citation Analysis]
4 Jin Y, Wu R, Li L, Shen L, Gu Y, Sun C. Exosomes from Inflamed Macrophages Promote the Progression of Parkinson's Disease by Inducing Neuroinflammation. Mol Neurobiol 2023. [PMID: 36596964 DOI: 10.1007/s12035-022-03179-6] [Reference Citation Analysis]
5 Avgerinos KI, Liu J, Dalamaga M. Could exercise hormone irisin be a therapeutic agent against Parkinson’s and other neurodegenerative diseases? Metabolism Open 2023. [DOI: 10.1016/j.metop.2023.100233] [Reference Citation Analysis]
6 Rehman MU, Sehar N, Dar NJ, Khan A, Arafah A, Rashid S, Rashid SM, Ganaie MA. Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments. Neurosci Biobehav Rev 2023;144:104961. [PMID: 36395982 DOI: 10.1016/j.neubiorev.2022.104961] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Meneses AD, Koga S, Li Z, O'Leary J, Li F, Chen K, Murakami A, Qiao W, Kurti A, Heckman MG, White L, Xie M, Chen Y, Finch NA, Lim MJ, Delenclos M, DeTure MA, Linares C, Martin NB, Ikezu TC, van Blitterswijk MM, Wu LJ, McLean PJ, Rademakers R, Ross OA, Dickson DW, Bu G, Zhao N. APOE2 Exacerbates TDP-43 Related Toxicity in the Absence of Alzheimer Pathology. Ann Neurol 2022. [PMID: 36546684 DOI: 10.1002/ana.26580] [Reference Citation Analysis]
8 Almgren H, Hanganu A, Camacho M, Kibreab M, Camicioli R, Ismail Z, Forkert ND, Monchi O. Motor symptoms in Parkinson's disease are related to the interplay between cortical curvature and thickness. Neuroimage Clin 2022;37:103300. [PMID: 36580712 DOI: 10.1016/j.nicl.2022.103300] [Reference Citation Analysis]
9 Angelopoulou E, Pyrgelis ES, Piperi C. Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence. Molecules 2022;27. [PMID: 36500540 DOI: 10.3390/molecules27238448] [Reference Citation Analysis]
10 Xu Q, Rydz C, Nguyen Huu VA, Rocha L, Palomino La Torre C, Lee I, Cho W, Jabari M, Donello J, Lyon DC, Brooke RT, Horvath S, Weinreb RN, Ju WK, Foik A, Skowronska-Krawczyk D. Stress induced aging in mouse eye. Aging Cell 2022;21:e13737. [PMID: 36397653 DOI: 10.1111/acel.13737] [Reference Citation Analysis]
11 Holden JM, Wareham LK. cGMP signaling: a potential therapeutic target for neurodegeneration in glaucoma? Neural Regen Res 2023;18:1267-8. [PMID: 36453407 DOI: 10.4103/1673-5374.360169] [Reference Citation Analysis]
12 Carradori S, Fantacuzzi M, Ammazzalorso A, Angeli A, De Filippis B, Galati S, Petzer A, Petzer JP, Poli G, Tuccinardi T, Agamennone M, Supuran CT. Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? Molecules 2022;27. [PMID: 36431918 DOI: 10.3390/molecules27227816] [Reference Citation Analysis]
13 Haider AA, Rex TS, Wareham LK. cGMP Signaling in the Neurovascular Unit—Implications for Retinal Ganglion Cell Survival in Glaucoma. Biomolecules 2022;12:1671. [DOI: 10.3390/biom12111671] [Reference Citation Analysis]
14 Wulf M, Barkovits K, Schork K, Eisenacher M, Riederer P, Gerlach M, Eggers B, Marcus K. The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies. Cells 2022;11. [PMID: 36428966 DOI: 10.3390/cells11223538] [Reference Citation Analysis]
15 Rossi SL, Subramanian P, Bu G, Di Polo A, Golde TE, Bovenkamp DE. Common features of neurodegenerative disease: exploring the brain-eye connection and beyond (part 2): the 2021 pre-symposium of the 15th international conference on Alzheimer's and Parkinson's diseases. Mol Neurodegener 2022;17:69. [PMID: 36316783 DOI: 10.1186/s13024-022-00571-7] [Reference Citation Analysis]
16 Croteau LP, Risner ML, Wareham LK, McGrady NR, Chamling X, Zack DJ, Calkins DJ. Ex Vivo Integration of Human Stem Retinal Ganglion Cells into the Mouse Retina. Cells 2022;11:3241. [PMID: 36291110 DOI: 10.3390/cells11203241] [Reference Citation Analysis]
17 Faiq MA, Sengupta T, Nath M, Velpandian T, Saluja D, Dada R, Dada T, Chan KC. Ocular manifestations of central insulin resistance. Neural Regen Res 2023;18:1139-46. [PMID: 36255004 DOI: 10.4103/1673-5374.355765] [Reference Citation Analysis]
18 Ramírez AE, Gil-jaramillo N, Tapias MA, González-giraldo Y, Pinzón A, Puentes-rozo PJ, Aristizábal-pachón AF, González J. MicroRNA: A Linking between Astrocyte Dysfunction, Mild Cognitive Impairment, and Neurodegenerative Diseases. Life 2022;12:1439. [DOI: 10.3390/life12091439] [Reference Citation Analysis]
19 Jiang H, Zhang Y, Yue J, Shi Y, Xiao B, Xiao W, Luo Z. Non-coding RNAs: The Neuroinflammatory Regulators in Neurodegenerative Diseases. Front Neurol 2022;13:929290. [DOI: 10.3389/fneur.2022.929290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Catalani E, Cherubini A, Del Quondam S, Cervia D. Regenerative Strategies for Retinal Neurons: Novel Insights in Non-Mammalian Model Organisms. Int J Mol Sci 2022;23:8180. [PMID: 35897754 DOI: 10.3390/ijms23158180] [Reference Citation Analysis]
21 Li X, Lu Y, Zhang S, Sai N, Fan Y, Cheng Y, Liu Q. Mechanism of Neural Regeneration Induced by Natural Product LY01 in the 5×FAD Mouse Model of Alzheimer’s Disease. Front Pharmacol 2022;13:926123. [DOI: 10.3389/fphar.2022.926123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Iorio R, Celenza G, Petricca S. Multi-Target Effects of ß-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation. Antioxidants (Basel) 2022;11:1199. [PMID: 35740096 DOI: 10.3390/antiox11061199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Beirowski B. Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration. Neurobiol Dis 2022;:105751. [PMID: 35569720 DOI: 10.1016/j.nbd.2022.105751] [Reference Citation Analysis]
24 Lohse MJ, Grehn F, Kuchenbecker J. Augenerkrankungen. Arzneiverordnungs-Report 2022 2022. [DOI: 10.1007/978-3-662-66303-5_29] [Reference Citation Analysis]
25 Salkov V, Voronkov D, Khudoerkov R. The role of mercury and arsenic in the etiology and pathogenesis of Parkinson’s and Alzheimer’s diseases. Arkh patol 2022;84:59. [DOI: 10.17116/patol20228405159] [Reference Citation Analysis]